Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies") ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

Cancer immunotherapy has reshaped cancer treatment by training the body's immune system to recognize and attack tumors. Drugs ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by ...

Ubiquitination is a crucial post-translational modification process where the small protein ubiquitin is attached to target proteins, marking them for degradation or altering their function. This ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia ...

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease.

According to MarketsandMarketstm, the Proteins & Protein Crystals Market is projected to grow from about USD 609.51 billion ...